Expression and Purification of Biologically Active Human Bone Morphogenetic Protein-4 in Recombinant Chinese Hamster Ovary Cells
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Bone morphogenetic protein-4 (BMP-4) is considered to have therapeutic potential for various diseases, including cancers; however, the high expression of biologically active recombinant human BMP-4 (rhBMP-4) needed for its manufacture for therapeutic purposes has yet to be established. In the current study, we established a recombinant Chinese hamster ovary (rCHO) cell line overexpressing rhBMP-4 as well as a production process using 7.5-l bioreactor (5 L working volume). The expression of the mature rhBMP-4 was significantly enhanced by recombinant furin expression. The combination of a chemically defined medium and a nutrient supplement solution for high expression of rhBMP-4 was selected and used for bioreactor cultures. The 11-day fed-batch cultures of the established rhBMP-4-expressing rCHO cells in the 7.5-L bioreactor produced approximately 32 mg/l of rhBMP-4. The mature rhBMP-4 was purified to homogeneity from the culture supernatant using a two-step chromatographic procedure, resulting in a recovery rate of approximately 55% and a protein purity greater than 95%. The N-terminal amino acid sequences and N-linked glycosylation of the purified rhBMP-4 were confirmed by N-terminal sequencing and de-N-glycosylation analysis, respectively. The mature purified rhBMP-4 has been proved to be functionally active, with an effective dose concentration of EC50 of 2.93 ng/ml.
Abstract
Bone morphogenetic protein-4 (BMP-4) is considered to have therapeutic potential for various diseases, including cancers; however, the high expression of biologically active recombinant human BMP-4 (rhBMP-4) needed for its manufacture for therapeutic purposes has yet to be established. In the current study, we established a recombinant Chinese hamster ovary (rCHO) cell line overexpressing rhBMP-4 as well as a production process using 7.5-l bioreactor (5 L working volume). The expression of the mature rhBMP-4 was significantly enhanced by recombinant furin expression. The combination of a chemically defined medium and a nutrient supplement solution for high expression of rhBMP-4 was selected and used for bioreactor cultures. The 11-day fed-batch cultures of the established rhBMP-4-expressing rCHO cells in the 7.5-L bioreactor produced approximately 32 mg/l of rhBMP-4. The mature rhBMP-4 was purified to homogeneity from the culture supernatant using a two-step chromatographic procedure, resulting in a recovery rate of approximately 55% and a protein purity greater than 95%. The N-terminal amino acid sequences and N-linked glycosylation of the purified rhBMP-4 were confirmed by N-terminal sequencing and de-N-glycosylation analysis, respectively. The mature purified rhBMP-4 has been proved to be functionally active, with an effective dose concentration of EC50 of 2.93 ng/ml.
참고문헌 (25)
- Celeste AJ, "Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone", Proc. Natl. Acad. Sci. USA, 87, pp.9843~9847 (1990)
- Wozney JM, "Novel regulators of bone formation:molecular clones and activities", Science, 242, pp.1528~1534 (1988)
- Miyazaki Y, "Bone morphogenetic protein 4 regulates the budding site and elongation of the mouse ureter", J. Clin. Invest, 105, pp.863~873 (2000)
- Winnier G, "Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse", Genes Dev, 9, pp.2105~2116 (1995)
- Bragdon B, "Bone morphogenetic proteins: a critical review", Cell Signal, 23, pp.609~620 (2011)
- Kim M, "BMPs and their clinical potentials", BMP Rep, 44, pp.619~634 (2011)
- Liu B, "Effect of bone morphogenetic protein 4 in the human brain glioma cell line U251", Cell Biochem. Biophys, 58, pp.91~96 (2010)
- Piccirillo SG, "Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells", Nature, 444, pp.761~765 (2006)
- Zhou Z, "Bone morphogenetic protein 4 inhibits cell proliferation and induces apoptosis in glioma stem cells", Cancer Biother. Radiopharm, 26, pp.77~83 (2011)
- Duggal R, "Vaccinia virus expressing bone morphogenetic protein-4 in novel glioblastoma orthotopic models facilitates enhanced tumor regression and long-term survival", J. Transl. Med, 11, pp.155~ (2013)
- Lombardo Y, "Bone morphogenetic protein 4induces differentiation of colorectal cancer stem cells and increases their response to chemotherapy in mice", Gastroenterology, 140, pp.297~309 (2011)
- Cui Y, "BMP-4 is proteolytically activated by furin and", or PC6 during vertebrate embryonic development, 1998, pp.17, 4735~4743
- Nelsen SM, "Site-specific cleavage of BMP4by furin, PC6, and PC7", J. Biol. Chem, 284, pp.27157~27166 (2009)
- Kim CL, "Alleviation of proteolytic degradation of recombinant human bone morphogenetic protein-4 by repeated batch culture of Chinese hamster ovary cells", Process Biochem, 51, pp.1078~1084 (2016)
- Bessa PC, "Expression, purification and osteogenic bioactivity of recombinant human BMP-4, -9, -10, -11 and -14", Protein Expr. Purif, 63, pp.89~94 (2009)
- Klosch B, "Expression and purification of biologically active rat bone morphogenetic protein-4 produced as inclusion bodies in recombinant Escherichia coli", Biotechnol. Lett, 27, pp.1559~1564 (2005)
- Huang Y, "Expression of codon optimized human bone morphogenetic protein 4 in Pichia pastoris", Biotechnol. Appl. Biochem, 61, pp.175~183 (2014)
- Kozak M., "Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs", Nucleic Acids Res, 12, pp.857~872 (1984)
- Yoon J, "Expression vector animal cells", US Patent Publication No. 20140038233, ~ (2014)
- Choi B, "Overproduction of recombinant human transforming growth factor beta 3 in Chinese hamster ovary cells", Protein Expr. Purif, 110, pp.102~106 (2015)
- Ciudad CJ, "Deletion analysis of the Chinese hamster dihydrofolate reductase gene promoter", J. Biol. Chem, 263, pp.16274~16282 (1988)
- Foster B, "Novel TGF-beta protein purification methods", US Patent Publication No. 20030036629 A1, ~ (2003)
- Zhang F, "The optimal dose of recombinant human osteogenic protein-1enhances differentiation of mouse osteoblast-like cells: an in vitro study", Arch. Oral Biol, 57, pp.460~468 (2012)
- Gasteiger E, "The Proteomics Protocols Handbook", pp.571~607 (2005), Humana, Press
- Isaacs NW., "Cystine knots", Curr. Opin. Struct. Biol, 5, pp.391~395 (1995)